Biochip Market Growth by $21.42 Bn, Globally at Expected CAGR In Upcoming Year Report Forecast to 2020 To 2027
The report presents a detailed analysis of the driving factors & opportunities, top-winning strategies, business performance of key players, top investment pockets, and competitive landscape. According to the report, the global biochip market was pegged at $9.04 billion in 2017 and is expected to reach $21.42 billion by 2025, registering a CAGR of 11.2% from 2018 to 2025.
Download Sample PDF Of Report@ https://www.alliedmarketresearch.com/request-sample/4359
Technological advancements in the sector and increased utilization in personalized medicines, cancer diagnostics, and treatment drive the growth of the global biochip market. However, high cost of R&D activities related to biochips hampers the market growth. On the other hand, improving the feasibility of biochips in drug discovery, proteomics, and genomics offers lucrative opportunities to the market players in future.
DNA chips segment to dominate the market: -
In 2017, the DNA chips segment dominated the market in terms of revenue, contributing more than one-third share, as they are cost effective and have widespread availability. However, the protein chips segment is expected to manifest the fastest CAGR of 12.9% by 2025, owing to the recent technological advancements. In addition, the lab-on-a-chip segment is expected to portray gradual growth during the forecast period.
Major market players: -
The key companies analyzed in the report include Abbott Laboratories, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific, Inc., Agilent Technologies Inc., Fluidigm Corporation, GE Healthcare, Cepheid Inc., and F. Hoffmann-La Roche AG. In addition, the report highlights key market strategies, such as partnerships, collaboration, mergers & acquisition, and new product launch, which have been adopted by these market players to sustain the intense competition in the industry.
Major application areas of the industry: -
The report analyzed key application areas including drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and others. In 2017, drug discovery & development segment accounted about 30% share of the total market, as biochips are widely used to identify the active ingredients of drugs. However, disease diagnostics segment is estimated to grow at the fastest CAGR of 12.2% through 2025, owing to the surge in use of biochips for detection of cancer and other immunological disorders.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4359
Biotechnology & pharmaceutical Companies segment to dominate the industry by 2025:-
Biotechnology & pharmaceutical companies segment contributed about two-thirds share of the total market, owing to high investment required for the development of a variety of biochip products. However, academic & research institutes segment is expected to register the fastest CAGR of 13.5% from 2018 to 2025, owing to the development of portable and user-friendly biochips, which can be used for academic purposes. In addition, the hospitals and diagnostics centers segment would show gradual growth during the study period.
Asia-Pacific region to portray fastest growth by 2025 :-
In 2017, Asia-Pacific region garnered about $2.02 billion and is expected to register the fastest CAGR of 12.4% during the forecast period owing to various factors such as rapidly changing healthcare infrastructure in developing economies including India and China. However, in 2017, North America was the largest revenue contributor to the global biochip market, accounting for about 41% share, owing to rise in adoption of advanced biochips and high competitor interest in the under-penetrated market.
Read More About This Report@ https://www.alliedmarketresearch.com/biochip-market
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biochip Market Growth by $21.42 Bn, Globally at Expected CAGR In Upcoming Year Report Forecast to 2020 To 2027 here
News-ID: 1949908 • Views: 388
More Releases from Allied Market Research
Luxury travel market is projected to reach $ 1,198,380.7 million by 2027, growin …
According to a new report published by Allied Market Research titled, “Luxury travel market by Type of Tour, Age Group, and Types of Traveler: Opportunity Analysis and Industry Forecast, 2021–2027,” The global luxury travel market is growing rapidly since last few years owing to the increase in interest of people in unique and exotic holiday destinations. Luxury travel is a niche market; however, it is gradually gaining market share in
Sports Gun Market Expected to Reach $2,779.0 Million by 2027
According to a new report published by Allied Market Research, titled, "Sports Gun Market By Gun Type, Application, And Distribution Channel: Global Opportunity Analysis And Industry Forecast, 2020–2027," the global sports gun market is expected to reach $2,779.0 Million by 2027 at a CAGR of 9.7%from 2020 to 2027.Sports gun is non-lethal weapon which is used in shooting sports such as target shooting, Benchreat shooting, popinjay, Clay pigeon shooting, trap
Global Travel Retail Market Expected to Reach $153.7 Billion by 2025 | DFS Group …
According to a new report published by Allied Market Research, titled,"Travel Retail Market by Product and Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025",the global travel retail market size was valued at $74.9 billion in 2017, and is projected to reach $153.7 billion by 2025, growing at a CAGR of 9.6% from 2018 to 2025. Perfumes & cosmetics segment has a strong customer base in the global travel
Theme Park Vacation Market is projected to reach $74.7 billion by 2026, register …
According to a new report published by Allied Market Research, titled, "Theme Park Vacation Market by Type, Age Group, Traveler Type, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026," the global theme park vacation market size was valued at $47.2 billion in 2018, and is projected to reach $74.7 billion by 2026, registering a CAGR of 6.0% from 2019 to 2026. Theme park is as an outdoor attraction,
More Releases for Biochip
Biochip Market Trends & Outlook 2019 | Danaher Corp., Illumina, Inc., Qiagen N.V …
The biochips market growth outlook is positive with significant growth potential for DNA microarray. There is pressure on biochip manufacturers to reduce prices of biochips from medical diagnostic companies and research organizations as biochip prices are limiting the growth of the market. At the same time, increasing use of biochips in pharmaceutical research and development activities, concerns regarding animal testing, rising use of DNA microarrays for cancer diagnosis is contributing
Biochip Market To Achieve Significant Gains and Forecast Between 2018 to 2025
Qyresearchreports include new market research report “Global Biochip Market Professional Survey Report 2018” to its huge collection of research reports. In molecular biology, biochips are essentially miniaturized laboratories that can perform hundreds or thousands of simultaneous biochemical reactions. Biochips enable researchers to quickly screen large numbers of biological analytes for a variety of purposes, from disease diagnosis to detection of bioterrorism agents. Digital microfluidic biochips have become one of the most
Biochip Products Market Research Analysis By Experts 2018 To 2025
Qyresearchreports include new market research report “Global Biochip Products Sales Market Report 2018” to its huge collection of research reports. Global Biochip Products market competition by top manufacturers/players, with Biochip Products sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Illumina Thermo Fisher Scientific Cellix GE Healthcare Randox BioDot PerkinElmer Roche Horiba Download Free exclusive Sample of this report: https://www.qyresearchreports.com/sample/sample.php?rep_id=1507482&type=S As every market is characterized by a unique set of competition between key players,
Global Biochip Market Professional Survey Report 2017
Researchmoz added Most up-to-date research on "Global Biochip Market Professional Survey Report 2017" to its huge collection of research reports. This report studies Biochip in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share
Biochip Market 2017 Trend, Analysis and Forecast to 2021
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has